1. Home
  2. WEAV vs BNTC Comparison

WEAV vs BNTC Comparison

Compare WEAV & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$6.77

Market Cap

507.2M

Sector

Technology

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$12.11

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEAV
BNTC
Founded
2011
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.2M
405.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WEAV
BNTC
Price
$6.77
$12.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$12.20
$28.25
AVG Volume (30 Days)
1.5M
235.3K
Earning Date
10-30-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$229,790,000.00
N/A
Revenue This Year
$19.19
N/A
Revenue Next Year
$15.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.34
N/A
52 Week Low
$5.64
$9.70
52 Week High
$17.63
$17.15

Technical Indicators

Market Signals
Indicator
WEAV
BNTC
Relative Strength Index (RSI) 57.82 40.35
Support Level $6.23 $12.78
Resistance Level $7.16 $13.68
Average True Range (ATR) 0.24 0.75
MACD 0.10 -0.01
Stochastic Oscillator 70.34 28.74

Price Performance

Historical Comparison
WEAV
BNTC

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: